Loading…
Reported covered position: Staff Dir./Chief Counsel, House Judiciary Cmte.;, Acting Asst. AG, Office of Leg. Affairs, DOJ; Dep., Asst. AG, Office of Legal Policy, DOJ; Dep. CoS, & Leg. Dir., Senator Lamar Alexander; Min. Staff, Dir., Senate Gov. Affairs Cmte; CoS, Senator Peter, Fitzgerald; Sr. Counsel, Senate Gov. Affairs Cmte.;, Chief Counsel, Senator Arlen Specter
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues Music Modernization Act, H.R. 4706
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2018 · second_quarter · 2A
IT Modernization.
Cybersecurity and Surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| SAP AMERICA INC. |
| 10 |
| 2016–2018 |
| AMERICAN WATCH ASSOCIATION | 9 | 2016–2018 |
| FAIR COALITION (INFORMAL COALITION) | 7 | 2013–2015 |
| LCR FRANCHISE FINANCE, LLC | 7 | 2016–2018 |
| MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) | 7 | 2016–2018 |
| GEORGETOWN UNIVERSITY | 6 | 2017–2018 |
| JW ALUMINUM | 6 | 2017–2018 |
| MR. DONALD E. GRAHAM | 6 | 2017–2018 |
| QUALCOMM INCORPORATED | 6 | 2017–2018 |
| AVANTEL S A S | 5 | 2015–2016 |
| NORTHROP GRUMMAN | 5 | 2016–2017 |
| AMERICAN COUNCIL ON EDUCATION ON BEHALF OF 568 PROJECT | 4 | 2015 |
| ILLUMINA, INC. | 4 | 2016 |
| KATRIN HANSING | 4 | 2014 |
| MONSTER ENERGY COMPANY | 4 | 2015 |
| AMERICAN COUNCIL ON EDUCATION | 3 | 2017–2018 |
| BACARDI NORTH AMERICA CORPORATION | 3 | 2016 |
| BACK9NETWORK INC. | 3 | 2014 |
| NATIONAL ASSOCIATION OF INDEPENDENT COLLEGES AND UNIVERSITIES | 3 | 2017 |
| ANHEUSER-BUSCH COMPANIES, INC. | 2 | 2015 |
| GREAT LAKES DREDGE & DOCK COMPANY | 2 | 2017 |
| MERCK & CO., INC. | 2 | 2015 |
| TENNIS CHANNEL | 2 | 2014 |
| CULTURAL CARE, INC., D/B/A CULTURAL CARE AU PAIR | 1 | 2018 |
| NT CONCEPTS, INC. | 1 | 2017 |
| SAMSUNG ELECTRONICS CO. LTD. | 1 | 2015 |
Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Synthetic Drug Control Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Music Modernization Act of 2017
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues Music Modernization Act, H.R. 4706
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
SCREEN Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
SCREEN Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Modernizing Drug Enforcement Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Comprehensive Addiction Resources Emergency Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
SOUND Disposal and Packaging Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Stop Illicit Drug Importation Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
SAFETY Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Long-Term Opioid Efficacy Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Protecting Seniors Access to Medicare Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
STRONGER Patents Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Protecting Medicare from Executive Action Act of 2017 (S. 251); STRONGER Patents Act (S.1390); Medicare Part D coverage gap closure.
STRONGER Patents Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Over-the-Counter Drug Safety, Innovation, and Reform Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Expanding Access to Low Cost Generic Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Expanding Access to Low Cost Generic Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Protecting Medicare from Executive Action Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Protecting Medicare from Executive Action Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Protecting Medicare from Executive Action Act of 2017 (S. 251); STRONGER Patents Act (S.1390); Medicare Part D coverage gap closure.
Opioid Crisis Response Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Comprehensive Addiction Resources Emergency Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Register of Copyrights Selection and Accountability Act of 2017
Client: MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) · Firm: COVINGTON & BURLING LLP
H.R. 1695 - Changing the method of selection of the Register of Copyrights.
Register of Copyrights Selection and Accountability Act of 2017
Client: MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) · Firm: COVINGTON & BURLING LLP
H.R. 1695 - Changing the method of selection of the Register of Copyrights.
Register of Copyrights Selection and Accountability Act of 2017
Client: MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) · Firm: COVINGTON & BURLING LLP
H.R. 1695 - Changing the method of selection of the Register of Copyrights.
Synthetic Drug Control Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Synthetic Drug Control Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Protecting Seniors Access to Medicare Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Protecting Seniors Access to Medicare Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
STRONGER Patents Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Protecting Medicare from Executive Action Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Protecting Medicare from Executive Action Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Safe and Affordable Drugs from Canada Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Defend Trade Secrets Act of 2015
Client: PROTECT TRADE SECRETS COALITION (INFORMAL COALITION) · Firm: COVINGTON & BURLING LLP
Promote passage of federal trade secrets legislation. S. 1890 - Defend Trade Secrets Act of 2016 (entire bill) H.R. 3326 - Defend Trade Secrets Act of 2015 (entire bill)
Defend Trade Secrets Act of 2016
Client: PROTECT TRADE SECRETS COALITION (INFORMAL COALITION) · Firm: COVINGTON & BURLING LLP
Promote passage of federal trade secrets legislation. S. 1890 - Defend Trade Secrets Act of 2016 (entire bill) H.R. 3326 - Defend Trade Secrets Act of 2015 (entire bill)
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSOCIATION OF BROADCASTERS · Firm: COVINGTON & BURLING LLP
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights
Need-Based Educational Aid Act of 2015
Client: AMERICAN COUNCIL ON EDUCATION ON BEHALF OF 568 PROJECT · Firm: COVINGTON & BURLING LLP
Reauthorization of the Need-Based Educational Aide Act, S. 1482 and H.R. 2604
Need-Based Educational Aid Act of 2015
Client: AMERICAN COUNCIL ON EDUCATION ON BEHALF OF 568 PROJECT · Firm: COVINGTON & BURLING LLP
Reauthorization of the Need-Based Educational Aide Act, S. 1482 and H.R. 2604
Need-Based Educational Aid Act of 2015
Client: AMERICAN COUNCIL ON EDUCATION ON BEHALF OF 568 PROJECT · Firm: COVINGTON & BURLING LLP
Reauthorization of the Need-Based Educational Aide Act, S. 1482 and H.R. 2604
Need-Based Educational Aid Act of 2015
Client: AMERICAN COUNCIL ON EDUCATION ON BEHALF OF 568 PROJECT · Firm: COVINGTON & BURLING LLP
Reauthorization of the Need-Based Educational Aide Act, S. 1482 and H.R. 2604
2018 · second_quarter · 2A
Intellectual property issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2018 · first_quarter · 1A
IT Modernization.
Cybersecurity and Surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
IT Modernization.
Cybersecurity and Surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Patent reform generally; Intellectual property/antitrust issues; International/antitrust issues; Diversity issues in patenting.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of
MICROSOFT CORP via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Computer science education.
Immigration--high-skilled visas.
Corporate tax reform.
Privacy--intelligence and surveillance; CLOUD ACT.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Protecting Medicare from Executive Action Act of 2017 (S. 251); STRONGER Patents Act (S.1390); Medicare Part D coverage gap closure.
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
NATIONAL ASSOCIATION OF BROADCASTERS via COVINGTON & BURLING LLP
2018 · second_quarter · 2T
Copyright issues related to broadcasting.
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues Music Modernization Act, H.R. 4706
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORP via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Immigration--high-skilled visas.
Privacy--intelligence and surveillance; CLOUD ACT.
Corporate tax reform.
Computer science education.
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Cybersecurity and Surveillance.
IT Modernization.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Patent reform generally; Intellectual property/antitrust issues; International/antitrust issues; Diversity issues in patenting.
Filing targets: Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
NATIONAL ASSOCIATION OF BROADCASTERS via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Copyright issues related to broadcasting.
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Intellectual property issues.
Filing targets: SENATE
COPART, INC via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Implementation and operation of the NMVTIS program.
Filing targets: Justice, Dept of (DOJ)
LCR FRANCHISE FINANCE, LLC via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Renewal of the EB-5 investor visa program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL ON EDUCATION via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CULTURAL CARE, INC., D/B/A CULTURAL CARE AU PAIR via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Regulatory issues related to cultural and educational exchange programs
Filing targets: State, Dept of (DOS)
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
AMERICAN WATCH ASSOCIATION via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
watch-specific anti-counterfeiting campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL ON EDUCATION via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Tax on endowments of institutions of higher education.
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BROADCASTERS via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Deductibility of advertising expenses.
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Copyright issues related to broadcasting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LCR FRANCHISE FINANCE, LLC via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Renewal of the EB-5 investor visa program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COPART, INC via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Implementation and operation of the NMVTIS program.
Filing targets: Justice, Dept of (DOJ)
MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Potential copyright law reform issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORP via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Privacy--intelligence and surveillance.
Corporate tax reform.
Computer science education.
Immigration--high-skilled visas.
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
IT Modernization.
Cybersecurity and Surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
NATIONAL ASSOCIATION OF INDEPENDENT COLLEGES AND UNIVERSITIES via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Possible exemption from federal antitrust laws for private, non-profit colleges and universities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHROP GRUMMAN via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Patent reform generally; Intellectual property/antitrust issues; International/antitrust issues; Diversity issues in patenting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16); STRONGER Patents Act (S.1390)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
AMERICAN WATCH ASSOCIATION via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
watch-specific anti-counterfeiting campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL ON EDUCATION via COVINGTON & BURLING LLP
2017 · fourth_quarter · RA
Extension of Deferred Action for Childhood Arrivals program.
NT CONCEPTS, INC. via COVINGTON & BURLING LLP
2017 · second_quarter · 2@
Backlog in Federal security clearance background investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORP via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Computer science education.
Immigration--high-skilled visas.
Corporate tax reform.
Patent legislation.
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Patent reform generally; Intellectual property/antitrust issues; International/antitrust issues; Diversity issues in patenting.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
IT Modernization.
Cybersecurity and Surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
NATIONAL ASSOCIATION OF INDEPENDENT COLLEGES AND UNIVERSITIES via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Possible exemption from federal antitrust laws for NAICU members.
COPART, INC via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Implementation and operation of the NMVTIS program.
Filing targets: Justice, Dept of (DOJ)
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BROADCASTERS via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Copyright issues related to broadcasting.
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Deductibility of advertising expenses.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LCR FRANCHISE FINANCE, LLC via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Renewal of the EB-5 investor visa program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHROP GRUMMAN via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
H.R. 1695 - Changing the method of selection of the Register of Copyrights.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN WATCH ASSOCIATION via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
watch-specific anti-counterfeiting campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION OF INDEPENDENT COLLEGES AND UNIVERSITIES via COVINGTON & BURLING LLP
2017 · third_quarter · RR
Possible exemption from federal antitrust laws for NAICU members.
MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
H.R. 1695 - Changing the method of selection of the Register of Copyrights.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BROADCASTERS via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Deductibility of advertising expenses.
Copyright issues related to broadcasting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LCR FRANCHISE FINANCE, LLC via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Renewal of the EB-5 investor visa program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COPART, INC via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Implementation and operation of the NMVTIS program.
Filing targets: Justice, Dept of (DOJ)
MICROSOFT CORP via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Corporate tax reform.
Privacy--intelligence and surveillance.
Patent legislation.
Computer science education.
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Drug importation; IPAB; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHROP GRUMMAN via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
IT Modernization.
Cybersecurity and Surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · first_quarter · 1A
Patent reform generally Intellectual property/antitrust issues International/antitrust issues
Filing targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Patent reform generally Intellectual property/antitrust issues International/antitrust issues
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), White House Office
AMERICAN WATCH ASSOCIATION via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
watch-specific anti-counterfeiting campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
NORTHROP GRUMMAN via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREAT LAKES DREDGE & DOCK COMPANY via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Assisting with naturalization process for company employee.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
LCR FRANCHISE FINANCE, LLC via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Renewal of the EB-5 investor visa program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BROADCASTERS via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Deductibility of advertising expenses.
Local Radio Freedom Act, H.Con.Res.13 Legislative matters concerning broadcast rights Copyright Office issues
Copyright issues related to broadcasting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COPART, INC via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Implementation and operation of the NMVTIS program.
Filing targets: Justice, Dept of (DOJ)
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
CMMI Part B demonstration; Implementation issues related to 21st Century Cures; Patent Litigation Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN WATCH ASSOCIATION via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
watch-specific anti-counterfeiting campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · first_quarter · RR
Application of Internal Revenue Code to "related persons"
Application of Internal Revenue Code to "related persons"
MICROSOFT CORP via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Immigration--high-skilled visas.
Privacy--intelligence and surveillance.
Computer science education.
Patent legislation.
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Cybersecurity and Surveillance.
IT Modernization.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, White House Office
ALKERMES, INC. via COVINGTON & BURLING LLP
2017 · first_quarter · 1T
We will advocate for bills and policies that support treatment for alcohol and opiod dependency.
We will advocate for bills and policies that support treatment for alcohol and opiod dependency in the criminal justice system.
Filing targets: Administration for Children & Families (ACF), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
MOTION PICTURE ASSOCIATION (FKA MOTION PICTURE ASSOCIATION OF AMERICA [MPAA]) via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
H.R. 1695 - Changing the method of selection of the Register of Copyrights.
Filing targets: HOUSE OF REPRESENTATIVES
GREAT LAKES DREDGE & DOCK COMPANY via COVINGTON & BURLING LLP
2017 · first_quarter · RR
Assisting with naturalization process for company employee.
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2017 · first_quarter · RR
Extension of Deferred Action for Childhood Arrivals program.
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2017 · first_quarter · RR
Extension of Deferred Action for Childhood Arrivals program.
AVANTEL S.A. via COVINGTON & BURLING LLP
2016 · first_quarter · 1A
Acquisition of spectrum from the Colombian government; U.S.-Colombia Trade Promotion Agreement telecommunications obligations
Filing targets: State, Dept of (DOS), U.S. Trade Representative (USTR)
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
IT Modernization.
Cybersecurity and Surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
NORTHROP GRUMMAN via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
CMMI Part B demonstration; 21st Century Cures; Patent Litigation Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COPART, INC via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Implementation and operation of the NMVTIS program
Filing targets: Justice, Dept of (DOJ)
NATIONAL ASSOCIATION OF BROADCASTERS via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Copyright issues related to broadcasting.
Local Radio Freedom Act, H.Con.Res.17 Legislative matters concerning broadcast rights Copyright Office issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LCR FRANCHISE FINANCE, LLC via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Renewal of the EB-5 investor visa program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN WATCH ASSOCIATION via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
watch-specific anti-counterfeiting campaign
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
MICROSOFT CORP via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Computer science education.
Privacy--intelligence and surveillance.
Corporate tax reform.
Patent legislation.
ILLUMINA, INC. via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Issues related to precision medicine, laboratory developed tests and next generation sequencing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
ALKERMES, INC. via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
We will advocate for bills and policies that support treatment for alcohol and opiod dependency.
We will advocate for bills and policies that support treatment for alcohol and opiod dependency in the criminal justice system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2016 · fourth_quarter · RR
Cybersecurity and Surveillance; IT Modernization.
Cybersecurity and Surveillance; IT Modernization.
LCR FRANCHISE FINANCE, LLC via COVINGTON & BURLING LLP
2016 · fourth_quarter · RR
Renewal of the EB-5 visa program.
COPART, INC via COVINGTON & BURLING LLP
2016 · third_quarter · Q3
Implementation and operation of the NMVTIS program
Filing targets: Justice, Dept of (DOJ)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patent legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patent legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Privacy--intelligence and surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Immigration--high-skilled visas.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Immigration--high-skilled visas.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE